Circulating biomarker isolation from liquid biopsy samples

Oct 9, 2017 1:00 PM–2:00 PM (EDT)
Duration: 1hrs
The analysis of circulating biomarkers in a patient’s blood holds significant potential for early disease detection and monitoring. Circulating DNA is the most commonly studied biomarker in the context of liquid biopsy research. However, in the last couple of years, free-circulating RNA has gained more attention for biomarker analysis and interpretation.

In this webinar, we will discuss the different types of circulating RNA biomarkers studied in liquid biopsy samples. A special focus will be given to the challenges and solutions for isolating circulating RNA.

Verena Schramm, Ph.D.

Dr. Verena Schramm is a Global Product Manager for NGS library preparation products at QIAGEN. She holds a degree in Molecular Biology and Bioinformatics from the University of Applied Sciences, Gelsenkirchen and has worked on various NGS-related applications in industry and academia since 2008. After completing her PhD at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany in 2014 and prior to joining QIAGEN, she worked for a Swiss start-up in the sector of Data Driven Medicine.